Integrated BioPharma Inc (INBP) stock
INBPOTCPharmaceutical PreparationsFiscal year ends June 30
$0.18+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Integrated BioPharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Integrated BioPharma's ebitda for the twelve months ending Jun 30, 2026 was -$2.41M, down 203.2% year over year. For fiscal 2026 it was -$2.41M, down 203.2% from the year before. The highest annual figure on record is $6.12M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$2.41M | -203.2% |
| FY2025 | Jun 30, 2025 | $2.34M | +319.0% |
| FY2024 | Jun 30, 2024 | $558.00K | +18.5% |
| FY2023 | Jun 30, 2023 | $471.00K | -84.7% |
| FY2022 | Jun 30, 2022 | $3.08M | -49.7% |
| FY2021 | Jun 30, 2021 | $6.12M | +71.4% |
| FY2020 | Jun 30, 2020 | $3.57M | +18.0% |
| FY2019 | Jun 30, 2019 | $3.03M | +48.1% |
| FY2018 | Jun 30, 2018 | $2.04M | -43.0% |
| FY2017 | Jun 30, 2017 | $3.58M | +45.2% |
| FY2016 | Jun 30, 2016 | $2.47M | +84.2% |
| FY2015 | Jun 30, 2015 | $1.34M | -23.2% |
| FY2014 | Jun 30, 2014 | $1.74M | +13.0% |
| FY2013 | Jun 30, 2013 | $1.54M | – |
| FY2012 | Jun 30, 2012 | -$147.00K | – |
| FY2011 | Jun 30, 2011 | -$8.00K | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$799.00K | -221.1% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$1.02M | -224.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$836.00K | -393.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $240.00K | -58.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $660.00K | +38.4% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $818.00K | +89.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $285.00K | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $575.00K | +2400.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $477.00K | +192.6% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $432.00K | +232.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$374.00K | -723.3% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $23.00K | -80.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $163.00K | -69.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $130.00K | -87.9% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $60.00K | -92.6% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $118.00K | -82.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $527.00K | -62.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $1.08M | -40.3% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $809.00K | -39.2% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $670.00K | -57.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $1.40M | +102.0% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $1.80M | +73.4% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $1.33M | +4.5% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $1.59M | +180.8% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $691.00K | +4.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $1.04M | -20.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $1.27M | +126.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $567.00K | +14.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $661.00K | -6.8% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $1.31M | +75.9% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $562.00K | +100.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $496.00K | +59.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $709.00K | -23.4% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $742.00K | +41.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $280.00K | -58.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $311.00K | -78.6% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $925.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $525.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $675.00K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $1.46M | – |
See a number that looks wrong?